National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No. 1) (Cth)

National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No. 1)¹

Select Legislative Instrument 2010 No. 49

I, QUENTIN BRYCE, Governor-General of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following Regulations under the National Health Act 1953.

Dated 24 March 2010

QUENTIN BRYCE

Governor-General

By Her Excellency’s Command

NICOLA ROXON

Minister for Health and Ageing

1Name of Regulations

These Regulations are the National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No. 1).

2Commencement

These Regulations commence on the day after they are registered.

3Amendment of National Health (Pharmaceutical Benefits) Regulations 1960

Schedule 1 amends the National Health (Pharmaceutical Benefits) Regulations 1960.

Schedule 1          Amendments

(regulation 3)

[1]          Regulation 9AAD

omit

[2]          Schedule 4

omit

[3]          Schedule 5, items 2 and 3

substitute

2	Zoton	Lansoprazole	Capsule 15 mg	Oral	1)  1 August 2008 2)  1 August 2009 3)  1 April 2010	1)   5% 2)   5% 3)   15%
3	Somac	Pantoprazole	Tablet (enteric coated) 20 mg (as sodium sesquihydrate)	Oral	1)  1 August 2008 2)  1 April 2010	1)   4% 2)   21%
	Somac	Pantoprazole	Tablet (enteric coated) 40 mg (as sodium sesquihydrate)	Oral

Note

1.All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See